Trial Profile
Effect of food on the pharmacokinetics of once-daily prolonged-release tacrolimus
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 15 Oct 2018
Price :
$35
*
At a glance
- Drugs Tacrolimus (Primary)
- Indications Allergic conjunctivitis; Atopic dermatitis; Coronary artery restenosis; Eye disorders; Graft-versus-host disease; Interstitial lung diseases; Lupus nephritis; Myasthenia gravis; Open-angle glaucoma; Psoriasis; Rheumatoid arthritis; Transplant rejection; Ulcerative colitis
- Focus Pharmacokinetics
- 01 Oct 2018 Status changed from recruiting to completed.
- 13 Dec 2017 New trial record